Project Description

Carla Mamolo, PhD, is a health economics and outcomes research scientist at Pfizer. Carla c0-leads Work Package 6. In her 15 years at Pfizer, Carla has worked in numerous therapeutic areas and has extensive experience leading HEOR activities for drugs throughout the different stages of development. She currently specializes in hematology drugs in development, and has a particular interest in the selection, analysis and reporting of patient-reported outcomes in clinical trials. Carla is the co-lead of WP6 (clinically meaningful change in cancer clinical trials), and is based in Connecticut, USA.